Understanding the variation of modern endoscopic ultrasound use in patients with oesophageal cancer (VALUE): protocol for a multi-methods study.
Kieran G Foley, Cherish Boxall, James Franklin...
https://pubmed.ncbi.nlm.nih.gov/40486070/Actively Recruiting
Led by University Hospital Southampton NHS Foundation Trust · Updated on 2026-04-30
160
Participants Needed
14
Research Sites
26 weeks
Total Duration
Researchers are studying the use of endoscopic ultrasound EUS in patients with oesophageal cancer to understand how often this procedure changes patient treatment plans. This observational study focuses on patients with potentially curable oesophageal cancer who have already undergone initial staging with CT and PET-CT scans. The study also explores opinions of both patients and clinicians regarding the role of EUS in cancer staging. EUS combines endoscopy with ultrasound to visualize the oesophageal wall and nearby lymph nodes, helping to determine tumor depth and spread. Patients undergo sedation for this invasive procedure, which requires specialized training to perform. The study will include patients receiving EUS as part of their standard care and will also interview clinicians and patients to gather qualitative insights about the procedure. Participants will be monitored to see if EUS changes their treatment management decisions made at baseline. Some patients and clinicians will be interviewed within six weeks after EUS to share their views. The research team will collect clinical staging details, treatment decisions, and patient and clinician opinions, aiming to better understand the current use and impact of EUS in oesophageal cancer care. The study will continue until the end of 2026.
CONDITIONS
Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)
B
Ben Lindfield
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital Southampton NHS Foundation Trust
Lead Sponsor
National Institute for Health Research, United Kingdom
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single procedure during standard care
Participants undergo endoscopic ultrasound (EUS) as part of their standard care staging pathway to assess the depth of tumour invasion and lymph node involvement, following prior CT and PET-CT scans.
1 visit (in-person)
Duration - Up to 6 weeks after EUS
Participants who receive EUS are observed to understand the impact of EUS on treatment decisions and to collect qualitative data through interviews about their opinions and experiences.
1 to 2 interviews (in-person or remote) depending on participant consent
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Kieran G Foley, Cherish Boxall, James Franklin...
https://pubmed.ncbi.nlm.nih.gov/40486070/University Hospital Southampton NHS Foundation Trust
Lead Sponsor
National Institute for Health Research, United Kingdom
Collaborating Sponsor